Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir

Background/Aims The influence of hepatic steatosis (HS) on chronic hepatitis B (CHB) is unclear. We evaluated the influence of the degree of HS, assessed using the controlled attenuation parameter (CAP) of transient elastography (TE), on treatment outcomes in CHB patients initiated on antiviral ther...

Full description

Bibliographic Details
Main Authors: David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2019-09-01
Series:Clinical and Molecular Hepatology
Subjects:
Fatty liver
Hepatitis B, Chronic
Antiviral agent
Online Access:http://e-cmh.org/upload/pdf/cmh-2018-0054.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2018-0054.pdf

Similar Items